Cargando…
Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer
BACKGROUND: Precision medicine with gene panel testing based on next-generation sequencing for patients with cancer is being used increasingly in clinical practice. HER2, which encodes the human epidermal growth factor receptor 2 (HER2), is a potentially important driver gene. However, therapeutic s...
Autores principales: | Harada, Yohei, Sato, Akemi, Nakamura, Hideaki, Kai, Keita, Kitamura, Sho, Nakamura, Tomomi, Kurihara, Yuki, Ikeda, Sadakatsu, Sueoka, Eisaburo, Kimura, Shinya, Sueoka-Aragane, Naoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872313/ https://www.ncbi.nlm.nih.gov/pubmed/36690964 http://dx.doi.org/10.1186/s12885-022-10428-3 |
Ejemplares similares
-
Origin of circulating free DNA in patients with lung cancer
por: Abe, Tomonori, et al.
Publicado: (2020) -
Absence of copy number gain of EGFR: A possible predictive marker of long‐term response to afatinib
por: Nakamura, Tomomi, et al.
Publicado: (2022) -
Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
por: Sato, Akemi, et al.
Publicado: (2018) -
Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments
por: Nakashima, Chiho, et al.
Publicado: (2018) -
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test
por: Harada, Yohei, et al.
Publicado: (2022)